Vistagen Therapeutics, Inc.
Vistagen is a biopharmaceutical company focused on developing and commercializing innovative treatments for mental health and neurological disorders. They are developing a new class of intranasal product candidates called "pherines." Their mission is to improve standards of care in anxiety and depression.
Offisielt Register
AI Kvalitetsanalyse
Tillitsscore Detaljer
Snarveier
Nettside Høydepunkter
🌟 Lignende Pålitelige Bedrifter
Kalaris Therapeutics, Inc.
Kalaris is a clinical-stage biopharmaceutical company dedicated to the development and commercialization of treatments for prevalent retinal diseases. They focus on innovative retinal treatments, including TH103, a potential best-in-class anti-VEGF agent for neovascular AMD. Kalaris aims to ease patient burden and improve outcomes in retinal disease management.
Vor Biopharma Inc.
Vor Bio is a biopharmaceutical company focused on reinventing autoimmune disease treatment by targeting its root causes. Their lead program, telitacicept, is a potential first-in-class dual BAFF/APRIL inhibitor designed to silence survival signals of harmful B cells, aiming to halt autoantibody production. Vor Bio is committed to advancing transformative therapies that move beyond symptom control. They aspire to become a global leader in targeted autoimmune disease therapeutics.
PUMA BIOTECHNOLOGY, INC.
Puma Biotechnology is a biopharmaceutical company dedicated to the acquisition, development, and commercialization of novel therapeutics for the treatment of cancer. They focus on in-licensing innovative drug candidates that have undergone clinical testing. Puma Biotechnology aims to improve cancer treatment through innovative drug development.